Theravance has commenced Phase 2b study desined to evaluate varying doses of TD-4208 in patients with moderate to severe chronic obstructive pulmonary disease (COPD). Theravance leveraged its multivalent approach of drug design to ...
Tags: drug, long-acting medicines, long-acting muscarinic antagonist
Horizon Pharma has commercially launched Rayos (prednisone) delayed release tablets in the US. Rayos is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma ...
Tags: Horizon Pharma, Rayos, rheumatoid arthritis
The US Patent and Trademark Office (USPTO) has granted a patent to Pearl Therapeutics' co-suspension formulation technology for inhaled combinations. The Patent No. 8,324,266 covers methods for treating pulmonary disease using Pearl's ...
Horizon Pharma RAYOS (prednisone) delayed-release tablets have received the US Food and Drug Administration (FDA) approval. The approved drug is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis ...
Tags: Horizon Pharma RAYOS delayed-release tablets, rheumatoid arthritis, RA
The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...
Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis
Sosei Group Corporation,Japan, has received a positive opinion for its Seebri Breezhaler (glycopyrronium bromide/NVA237),a type of bronchodilator, from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). ...
Tags: Seebri Breezhaler, bronchodilator, CHMP, Positive Chmp Opinion
UK based Prosonix has signed a collaborative research agreement with Imperial College London to accelerate the development of engineered multi-component particles (MCPs) as respiratory medicines. As part of the collaboration, Prosonix ...
Tags: collaborative research agreement, multi-component particles
Astellas Pharma and AstraZeneca have announced the approval of the dry-power inhaler Symbicort Turbuhaler for the additional indication of chronic obstructive pulmonary disease(COPD). Symbicort Turbuhaler is a combination product ...
Tags: Astellas Pharma, AstraZeneca, dry-power inhaler Symbicort Turbuhaler
HTG Molecular Diagnostics has gained rights to commercialize the Centre of Excellence for the Prevention of Organ Failure's(PROOF Centre)-developed gene expression blood tests,following the finalization of the license agreement. The gene ...
Tags: HTG Molecular Diagnostics, Prevention of Organ Failure, COPD, qNPA
Pulmatrix has announced the results of a clinical study showing that an iCALM (inhaled cationic airway lining modulator therapy) attenuated allergen-induced bronchitis in susceptible asthmatic patients. The study concluded that iCALM is a ...
Boehringer Ingelheim and Funxional Therapeutics have signed an agreement under which Boehringer will acquire the global rights to Funxional's FX125L compound and somatotaxin program. Boehringer is responsible for all further research, ...
Aptar Pharma, a manufacturer of nasal and pulmonary drug delivery devices, has launched Twister, a new capsule-based Dry Powder Inhaler (DPI) for asthma sufferers. Twister is a transparent device that operates by three simple steps: ...
Tags: Aptar Pharma, drug delivery devices, DPI
GlaxoSmithKline (GSK) and Theravance have announced the regulatory submissions for furoate FF/vilanterol VI (FF/VI) to treat chronic obstructive pulmonary disease (COPD) in the US and Europe. The companies also announced regulatory ...
ALung Technologies has presented data from Hemolung respiratory assist system's (RAS) clinical trial. The trial enrolled seven patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) who were failing non-invasive ...
Tags: clinical trial, emolung respiratory assist system, COPD
An air purifier is a device which removes contaminants from the air. These devices are commonly marketed as being beneficial to allergy sufferers and asthmatics, and at reducing or eliminating second-hand tobacco smoke. Commercial grade air ...
Tags: Industry Knowledge, Learning Center, Air purifier, Purifier&Filter